Urticaria, angioedema and dyspnoea in adjuvant therapy of melanoma with interferon α-2b

Acta Dermato-Venereologica

Volumn 90, Issue 3, 2010, Pages 308-309

  Helbig, Doris ^a   Simon, Jan Christoph ^a   Treudler, Regina ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DIMETINDENE; IBUPROFEN; METHYLPREDNISOLONE; PARACETAMOL; RECOMBINANT ALPHA2B INTERFERON;

ADJUVANT THERAPY; ADULT; ALOPECIA; ANGIONEUROTIC EDEMA; CASE REPORT; DRUG TOLERABILITY; DYSPNEA; ECZEMA; HAIR DISCOLORATION; HUMAN; LETTER; LOW DRUG DOSE; MALE; MELANOMA; PRICK TEST; PRIORITY JOURNAL; PRURITUS; URTICARIA;

ANGIOEDEMA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; DIMETHINDENE; DRUG HYPERSENSITIVITY; DYSPNEA; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; INTERFERON ALFA-2B; MALE; MELANOMA; METHYLPREDNISOLONE; MIDDLE AGED; SKIN NEOPLASMS; TREATMENT OUTCOME; URTICARIA;

EID: 77953457685     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0826     Document Type: Letter

References (11)

1. Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Kortmann RD, et al. Deutsche Leitlinie: Malignes Melanom. In: Garbe C (Hrsg.). Interdisziplinäre Leitlinien zur Diagnostik und Behandlung von Hauttumoren. Stuttgart: Georg Thieme Verlag, 2005: p. 23-55.
2. Guillot B, Blazquez L, Bessis D, Dereure O, Guilhou JJ. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma. Dermatology 2004; 208: 49-54.
3. Mannering GJ, Deloria LB. The pharmacology and toxicology of the interferons: an overview. Ann Rev Pharmacol Toxicol 1986; 26: 455-515.
4. Siegel DS, Le J, Vilcek J. Modulation of lymphocyte proliferation and immunoglobulin synthesis by interferon-gamma and "type I" interferons. Cell Immunol 1986; 101: 380-390.
5. Knop J, Taborski B, DeMaeyer-Guignard J. Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J Immunol 1987; 138: 3684-3687. (Pubitemid 17078234)
6. Torrelo A, Harto A, Ledo A. Interferon therapy for chronic urticaria. J Am Acad Dermatol 1995; 32: 684-685.
7. Marcellin P, Pouteau M, Martinot-Peignoux M, Degos F, Duchatelle V, Boyer N, et al. Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C. Gastroenterology 1995; 109: 156-165.
8. Pardini S, Bosincu L, Bonfigli S, Dore F, Longinotti M. Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon. Acta Haematol 1991; 85: 220.
9. Livni E, Lapidoth M, Halevy S. In vitro release of interferon-gamma and macrophage migration inhibition factor in drug-induced urticaria and angioedema. Acta Derm Venereol 1999; 79: 18-22.
10. Reznikov LL, Puren AJ, Fantuzzi G, Muhl H, Shapiro L, Yoon DY, et al. Spontaneous and inducible cytokine responses in healthy humans receiving a single dose of IFN-alpha2b: increased production of interleukin-1 receptor antagonist and suppression of IL-1-induced IL-8. J. Interferon Cytokine Res 1998; 18: 897-903. (Pubitemid 28489669)
11. Kalpaklioglu AF, Baccioglu KA, Erdemoglu AK. Desensitization in interferon-beta1a allergy: A case report. Int Arch Allergy Immunol 2009; 149: 178-180.